Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, GPT Healthcare has informed that the Company will be meeting with Investors/ Analysts on Thursday, March 27, 2025, the details of which are enclosed. The Investor Presentation (Q3FY25) - December 2024, is already in the public domain and is available on the Company's and the Stock Exchanges’ websites. The said presentation would be used in the meeting. Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the meeting. Changes may happen due to exigencies on the part of Investors/Analysts/Company.
The above information is a part of company’s filings submitted to BSE.
